Tandem Diabetes Care reported a quarterly loss of $0.30 per share, beating the Zacks Consensus Estimate for a $0.46 loss. That also marks an improvement from a $0.67 loss per share in the same quarter last year. The print is supportive for sentiment, though the article provides no revenue or guidance details.
Tandem Diabetes Care reported a quarterly loss of $0.30 per share, beating the Zacks Consensus Estimate for a $0.46 loss. That also marks an improvement from a $0.67 loss per share in the same quarter last year. The print is supportive for sentiment, though the article provides no revenue or guidance details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
